- Home
- FGEN vs NYC Comparison
FGEN vs NYC Comparison
Compare FGEN & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- NYC
- Stock Information
- Founded
- FGEN 1993
- NYC 2013
- Country
- FGEN United States
- NYC United States
- Employees
- FGEN N/A
- NYC N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- FGEN Health Care
- NYC Finance
- Exchange
- FGEN Nasdaq
- NYC Nasdaq
- Market Cap
- FGEN 33.5M
- NYC 27.6M
- IPO Year
- FGEN 2014
- NYC N/A
- Fundamental
- Price
- FGEN $0.31
- NYC $11.47
- Analyst Decision
- FGEN Strong Buy
- NYC
- Analyst Count
- FGEN 1
- NYC 0
- Target Price
- FGEN $10.00
- NYC N/A
- AVG Volume (30 Days)
- FGEN 514.9K
- NYC 5.2K
- Earning Date
- FGEN 05-12-2025
- NYC 05-09-2025
- Dividend Yield
- FGEN N/A
- NYC N/A
- EPS Growth
- FGEN N/A
- NYC N/A
- EPS
- FGEN N/A
- NYC N/A
- Revenue
- FGEN $29,621,000.00
- NYC $58,397,000.00
- Revenue This Year
- FGEN $232.81
- NYC $8.40
- Revenue Next Year
- FGEN $9.16
- NYC $1.62
- P/E Ratio
- FGEN N/A
- NYC N/A
- Revenue Growth
- FGEN N/A
- NYC N/A
- 52 Week Low
- FGEN $0.18
- NYC $7.55
- 52 Week High
- FGEN $1.74
- NYC $13.59
- Technical
- Relative Strength Index (RSI)
- FGEN 46.75
- NYC 52.12
- Support Level
- FGEN $0.28
- NYC $10.68
- Resistance Level
- FGEN $0.34
- NYC $11.71
- Average True Range (ATR)
- FGEN 0.02
- NYC 0.58
- MACD
- FGEN 0.00
- NYC -0.05
- Stochastic Oscillator
- FGEN 37.50
- NYC 37.89
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.